Correction to: Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells

Springer Science and Business Media LLC - Tập 12 - Trang 1-2 - 2019
Kai Zhao1, Yuxin Zhou1, Chen Qiao1, Ting Ni1, Zhiyu Li2, Xiaotang Wang3, Qinglong Guo1, Na Lu1, Libin Wei1
1State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing, People’s Republic of China
2Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing, People’s Republic of China
3Department of Chemistry and Biochemistry, Florida International University, Miami, USA

Tóm tắt

The original article [1] contains several errors.

Tài liệu tham khảo

Zhao K, Zhou Y, Qiao C, Ni T, Li Z, Wang X, et al. Oroxylin a promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells. J Hematol Oncol. 2015;8:41 https://doi.org/10.1186/s13045-015-0137-1.
Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 12

1-2

Thông tin tác giả